Cargando…

An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005–2011

BACKGROUND: Despite high vaccination coverage, infection with Bordetella pertussis is a current public health concern in the Netherlands and other European Union member states. Because surveillance data are subject to extensive under-ascertainment and under-reporting, incidence is difficult to deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonald, Scott A., Teunis, Peter, van der Maas, Nicoline, de Greeff, Sabine, de Melker, Hester, Kretzschmar, Mirjam E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696101/ https://www.ncbi.nlm.nih.gov/pubmed/26715486 http://dx.doi.org/10.1186/s12879-015-1324-y

Ejemplares similares

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011
por: van Lier, Alies, et al.
Publicado: (2016)

The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis
por: Teirlinck, A. C., et al.
Publicado: (2018)

Hospitalization due to varicella in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2011)

Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries
por: Kretzschmar, Mirjam, et al.
Publicado: (2010)

Pertussis hospitalizations among term and preterm infants: clinical course and vaccine effectiveness
por: van der Maas, Nicoline A. T., et al.
Publicado: (2019)

Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020
por: Middeldorp, Marit, et al.
Publicado: (2021)

An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2014)

Estimation of HIV incidence in Brazil, 2005-2011
por: Szwarcwald, Celia Landmann, et al.
Publicado: (2014)

The use of tetanus post-exposure prophylaxis guidelines by general practitioners and emergency departments in the Netherlands: a cross-sectional questionnaire study
por: Donken, Robine, et al.
Publicado: (2014)

Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants
por: Immink, Maarten M., et al.
Publicado: (2021)

Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
por: Mooi, Frits R., et al.
Publicado: (2009)

The estimated disease burden of acute COVID-19 in the Netherlands in 2020, in disability-adjusted life-years
por: McDonald, Scott A., et al.
Publicado: (2022)

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.
por: de Melker, H E, et al.
Publicado: (2000)

Maternal vaccination against pertussis as part of the national immunization program: a qualitative evaluation among obstetric care providers one year after the implementation in December 2019
por: Immink, Maarten M., et al.
Publicado: (2023)

Tolerability of Early Measles-Mumps-Rubella Vaccination in Infants Aged 6–14 Months During a Measles Outbreak in The Netherlands in 2013–2014
por: van der Maas, Nicoline A. T., et al.
Publicado: (2016)

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
por: de Melker, H E, et al.
Publicado: (1997)

Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model
por: de Vries, Robin, et al.
Publicado: (2010)

Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands
por: van Lier, Alies, et al.
Publicado: (2019)

Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, January 6, 2021 through August 30, 2022
por: van Iersel, Senna C.J.L., et al.
Publicado: (2023)

Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
por: Rodenburg, Gerwin D., et al.
Publicado: (2010)

Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
por: van Deursen, Anna M.M., et al.
Publicado: (2012)

Regional differences in historical diphtheria and scarlet fever notification rates in The Netherlands, 1905–1925: a spatial-temporal analysis
por: McDonald, Scott A., et al.
Publicado: (2023)

Baseline incidence of intussusception in early childhood before rotavirus vaccine introduction, the Netherlands, January 2008 to December 2012
por: Gadroen, Kartini, et al.
Publicado: (2017)

Prevalence, diagnosis, and disease course of pertussis in adults with acute cough: a prospective, observational study in primary care
por: Teepe, Jolien, et al.
Publicado: (2015)

Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021
por: Steens, Anneke, et al.
Publicado: (2021)

Pertussis Incidence by Time, Province and Age Group in Iran, 2006–2011
por: KHAZAEI, Salman, et al.
Publicado: (2016)

Evaluation of the surveillance system for invasive meningococcal disease (IMD) in the Netherlands, 2004–2016
por: Brandwagt, Diederik A. H., et al.
Publicado: (2019)

Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of Bordetella pertussis Despite High Vaccination Rates
por: Scott, Susana, et al.
Publicado: (2015)

Tularemia Transmission to Humans, the Netherlands, 2011–2021
por: Rijks, Jolianne M., et al.
Publicado: (2022)

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection
por: van der Lee, Saskia, et al.
Publicado: (2017)

The impact of demographic change on the estimated future burden of infectious diseases: examples from hepatitis B and seasonal influenza in the Netherlands
por: McDonald, Scott A, et al.
Publicado: (2012)

Implementation of MenACWY vaccination because of ongoing increase in serogroup W invasive meningococcal disease, the Netherlands, 2018
por: Knol, Mirjam J, et al.
Publicado: (2018)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

The Clinical Picture and Severity of Invasive Meningococcal Disease Serogroup W Compared With Other Serogroups in the Netherlands, 2015–2018
por: Loenenbach, Anna D, et al.
Publicado: (2020)

Time series analysis of temporal trends in the pertussis incidence in Mainland China from 2005 to 2016
por: Zeng, Qianglin, et al.
Publicado: (2016)

The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older
por: Lehmann, Birthe A., et al.
Publicado: (2017)

Measles Outbreak, the Netherlands, 2008
por: Hahné, Susan, et al.
Publicado: (2010)

Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
por: McDonald, Scott A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9q15nkq93vacq2h22ihhh3kt4e